Search - Archive ouverte HAL Access content directly

Filter your results

15 Results
Structure: Internal structure identifier : 42648

Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.

Hélène Labussière Wallet , Mohamad Sobh , Stéphane Morisset , Marie Robin , Nathalie Fegueux et al.
Experimental Hematology, 2013, 41 (11), pp.924-933. ⟨10.1016/j.exphem.2013.05.297⟩
Journal articles hal-00849674v1
Image document

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

Gandhi Damaj , Alain Duhamel , Marie Robin , Yves Beguin , Mauricette Michallet et al.
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal articles inserm-00821506v1

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Philippe Moreau , Frédéric Garban , Michel Attal , Mauricette Michallet , Gérald Marit et al.
Blood, 2008, 112 (9), pp.3914-5. ⟨10.1182/blood-2008-07-168823⟩
Journal articles hal-00821148v1

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Mauricette Michallet , Quoc-Hung Le , Mohamad Mohty , Thomas Prébet , Franck Nicolini et al.
Experimental Hematology, 2008, 36 (5), pp.535-44. ⟨10.1016/j.exphem.2008.01.017⟩
Journal articles istex inserm-00484237v1

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Marie Robin , Reza Tabrizi , Mohamad Mohty , Sabine Furst , Mauricette Michallet et al.
British Journal of Haematology, 2011, 152 (3), pp.331-9. ⟨10.1111/j.1365-2141.2010.08417.x⟩
Journal articles hal-00849650v1

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup

A. Hospital , T. Prebet , S. Bertoli , X. Thomas , E. Tavernier et al.
Blood, 2014, 124 (8), pp.1312 - 1319. ⟨10.1182/blood-2014-01-549212⟩
Journal articles hal-01688071v1
Image document

Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial

Nicolas Boissel , Aline Renneville , Thibaut Leguay , Pascale Cornillet Lefebvre , Christian Recher et al.
Haematologica, 2015, 100 (6), pp.780 - 785. ⟨10.3324/haematol.2014.114884⟩
Journal articles inserm-01820455v1

Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience

Hervé Avet-Loiseau , Cyrille Hulin , Loic Campion , Philippe Rodon , Gerald Marit et al.
Journal of Clinical Oncology, 2013, 31 (22), pp.2806--2809. ⟨10.1200/JCO.2012.46.2598⟩
Journal articles hal-01064339v1

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Jean-Luc Harousseau , Herve Avet-Loiseau , Michel Attal , Catherine Charbonnel , Frederic Garban et al.
Journal of Clinical Oncology, 2009, 27 (34), pp.5720-6. ⟨10.1200/JCO.2008.21.1060⟩
Journal articles hal-00821143v1

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

Patrice Chevallier , Richard M Szydlo , Didier Blaise , Reza Tabrizi , Mauricette Michallet et al.
Biology of Blood and Marrow Transplantation, 2012, 18 (2), pp.289-94. ⟨10.1016/j.bbmt.2011.07.013⟩
Journal articles hal-00849660v1

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Bruno Lioure , Marie C Béné , Arnaud Pigneux , Anne Huynh , Patrice Chevallier et al.
Blood, 2012, 119 (12), pp.2943-8. ⟨10.1182/blood-2011-05-352989⟩
Journal articles hal-00849702v1

Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study

A. Desjonqueres , P. Chevallier , X. Thomas , F. Huguet , T. Leguay et al.
Blood Cancer Journal, 2016, 6, pp.e504. ⟨10.1038/bcj.2016.111⟩
Journal articles hal-01792626v1
Image document

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience

Marie-Anne Couturier , Françoise Huguet , Patrice Chevallier , Felipe Suarez , Xavier Thomas et al.
American Journal of Hematology, 2015, 90 (11), pp.986--991. ⟨10.1002/ajh.24130⟩
Journal articles hal-01231425v1

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu , Michel Attal , Bertrand Arnulf , Philippe Moreau , Catherine Traulle et al.
Blood, 2013, 121 (11), pp.1968--1975. ⟨10.1182/blood-2012-09-452375⟩
Journal articles hal-01064417v1

Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Michel Attal , Valerie Lauwers-Cances , Gerald Marit , Denis Caillot , Philippe Moreau et al.
New England Journal of Medicine, 2012, 366 (19), pp.1782-91. ⟨10.1056/NEJMoa1114138⟩
Journal articles hal-00852275v1